Mumbai: Shares of Divi’s Laboratories Ltd on Thursday fell as much as 6.3% to hit a low of over five months after the company said the US Food and Drug Administration (USFDA) has issued Form 483 for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback